Scientific Session
Immunobiology
Michel Sadelain, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, United States
Disclosure(s): Atara Biotherapeutics, Inc.,: Grant/Research Support (Ongoing), Ownership Interest (Ongoing); Fate Therapeutics: Grant/Research Support (Ongoing), Ownership Interest (Ongoing); Juno Therapeutics: Ownership Interest (Ongoing); Mnemo Therapeutics: Grant/Research Support (Ongoing), Ownership Interest (Ongoing); Takeda Pharmaceutical Company, Ltd.,: Grant/Research Support (Ongoing), Ownership Interest (Ongoing)